Galmed Pharmaceuticals Ltd.

GLMDNASDAQHealthcare● Active

$0.46

$-0.01(-2.47%)

Market Cap$2507844

P/E Ratio—

52W High$2.34

52W Low$0.411

Avg Volume3.0M

Open$0.46

Beta0.71

Cash on Hand Financials Revenue

Galmed Pharmaceuticals Ltd. (GLMD) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

GLMD · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$18.2M▲ +18.4% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$4.0M

cashAndCashEquivalents

Short-Term Investments

$14.2M

shortTermInvestments

YoY Change vs Prior Year

+18.4%

vs prior fiscal year

Latest Quarter

$18.2M

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$18.2MCash on Hand

Total Debt$0Total Debt

Net Cash / Net Debt+$18.2MNet Cash Position

Cash vs Debt Ratio

Cash 100%Galmed Pharmaceuticals Ltd. cash as % of market cap: 723.97%% · MCap $0BDebt 0%

Galmed Pharmaceuticals Ltd. has a net cash position of $18.2M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$18.2M − $0 = +$18.2M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

GLMD annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

GLMD cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$18.2M+18.4%

Dec 31, 2024FY$15.3M+21.3%

Dec 31, 2023FY$12.6M-8.3%

Dec 31, 2022FY$13.8M-60.4%

Dec 31, 2021FY$34.8M-31.6%

GLMD cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

GLMD vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Galmed Pharmaceuticals Ltd.YOU

GLMD

$18.2M$3M724.0%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Galmed Pharmaceuticals Ltd. (GLMD) cash on hand as of December 31, 2025 is $18.2M, comprising $4.0M in cash and cash equivalents (CCE) plus $14.2M in short-term investments — reported as Galmed Pharmaceuticals Ltd. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Galmed Pharmaceuticals Ltd. cash reserves or cash position.

Galmed Pharmaceuticals Ltd. annual cash on hand history shows increased +18.4% in 2025: increased +18.4% in 2025. Galmed Pharmaceuticals Ltd. cash reserves in 2025 reflect the company's capital allocation strategy.

Galmed Pharmaceuticals Ltd. carries total debt of $0 against cash of $18.2M, resulting in a net cash position of +$18.2M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

GLMD cash on hand · 5 questions

As of December 31, 2025, Galmed Pharmaceuticals Ltd. (GLMD) has $18,156,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $3,985,000 in cash and cash equivalents (CCE) plus $14,171,000 in short-term investments. Latest quarter (December 31, 2025): $18,156,000. Data sourced from the annual 10-K filing via FMP.

GLMD cash on handGLMD cash reservesGLMD cash 2025how much cash does GLMD have

▸ Source: FMP /balance-sheet-statement · US GAAP · Galmed Pharmaceuticals Ltd. · Galmed Pharmaceuticals Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025